0397 (0397) Fair Value & Analysis

Financial Services · Market cap HK$84.2M

0 0397 0397 · HK

PriceHK$0.0360

Fair ValueHK$0.0490

Upside+36.0%

Quality57/100

Evidence: Low Range HK$0.0446 – HK$0.0511

Fair value as of: Jul 1, 2026

From 7 valuation models · updated today

Share price −10.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0350 – HK$0.0702 · fair‑value band HK$0.0446 – HK$0.0511 · the HK$0.0360 price screens below the HK$0.0490 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0397 (0397) currently trades at HK$0.0360, while our model-based Fair Value estimate is HK$0.0490 — implying the stock looks roughly 36.0% undervalued today. We read business quality at 57/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Trailing-twelve-month revenue stands at HK$56.1M. Revenue declined 22.3% year over year. It earns a return on equity of -5.7%. The balance sheet holds a net cash position of HK$135M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$56.1M

Revenue growth (YoY) -22.3%

Net margin -111%

Return on equity -5.7%

Free cash flow HK$15.7M FY2025

Operating margin 12.9%

More key figures

EPS (TTM) HK$-0.0100

EPS growth (YoY) +1,482%

Net cash HK$135M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0397 reported revenue of HK$69.4M in FY2025 versus HK$95.7M in FY2021, a compound −7.7%/yr. Reported net income was −HK$62.4M in FY2025.

Revenue −7.7%/yr

FY21 HK$95.7M

FY22 HK$75.4M

FY23 HK$76.2M

FY24 HK$70.1M

FY25 HK$69.4M

Net income

FY21 HK$154M

FY22 −HK$171M

FY23 −HK$104M

FY24 −HK$144M

FY25 −HK$62.4M

Is 0397 fairly valued? → Check now

Similar stocks

6 more Financial Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
ORIX Corporation IX	$40.36	$35.63	-12%
Bajaj Finserv Ltd BAJAJFINSV	₹1,765	₹682.39	-61%
Yuanta Financial Holding 2885	68.30 TWD	40.61 TWD	-41%
China Galaxy Securities Co 601881	¥13.04	¥22.47	+72%
Guosen Securities Co 002736	¥10.37	¥17.69	+71%
CNPC Capital Company 000617	¥7.51	¥7.09	-6%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0397 (0397) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.0490 versus a price of HK$0.0360 — about +36% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0397?

Our model-based fair value for 0397 is HK$0.0490 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.0360.

What is the quality score of 0397?

0397 has a Quality Score of 57/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0397 (0397)?

0397 reported trailing-twelve-month revenue of about HK$56.1M (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0397?

The net profit margin of 0397 is about -111.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.